City

Cincinnati (1)

Dallas (1)

Houston (1)

Lubbock (1)

Memphis (1)

Milwaukee (1)

Oklahoma City (1)

Condition

Recurrent or Refractory Solid Tumors (2)

CNS Malignancies (1)

Ewing Sarcoma (1)

Neuroblastoma (1)

Osteosarcoma (1)

Rhabdomyosarcoma (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

South Plains Oncology Consortium (1)

St. Jude Children's Research Hospital (1)

Collaborator

Novartis Pharmaceuticals (1)

Intervention

bevacizumab (1)

everolimus (1)

mm-398 (irinotecan sucrosofate liposome injection) plus cyclophosphamide (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

recurrent or refractory solid tumors

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma Trial in United States (MM-398 (Irinotecan Sucrosofate

Recruiting

Recurrent or Refractory Solid Tumors
+4 more

MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide

Cincinnati, Ohio
+5 more

Mar 17, 2022

Recurrent or Refractory Solid Tumors, CNS Malignancies Trial in Memphis (Bevacizumab, Everolimus)

Completed

Recurrent or Refractory Solid Tumors
CNS Malignancies

Memphis, Tennessee

St. Jude Children's Research Hospital

Oct 13, 2015